# Amgen Inc. (AMGN) — Q3-2019 Earnings Results

**Report date:** 2019-10-29 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2019

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 1.94%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.66 | N/A | +0.03% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to patient care and shareholder value. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to patients and shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's slight EPS beat indicates solid performance in managing costs and profitability. The stock's 1.94% increase reflects investor confidence in the company's ability to deliver value, despite the lack of revenue data and future guidance. Investors may view the EPS beat as a positive sign for ongoing operations.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2019_